Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ikuya Shiromizu is active.

Publication


Featured researches published by Ikuya Shiromizu.


Acta Crystallographica Section D-biological Crystallography | 2004

Structure of aldolase from Thermus thermophilus HB8 showing the contribution of oligomeric state to thermostability.

Neratur K. Lokanath; Ikuya Shiromizu; Noriyasu Ohshima; Yuichi Nodake; Mitsuaki Sugahara; Shigeyuki Yokoyama; Seiki Kuramitsu; Masashi Miyano; Naoki Kunishima

2-Deoxyribose-5-phosphate aldolase catalyzes a reversible aldol condensation of two aldehydes via formation of a covalent Schiff-base intermediate at the active lysine residue. The crystal structure of 2-deoxyribose-5-phosphate aldolase from Thermus thermophilus HB8 has been determined with and without the substrate at atomic resolution. This enzyme, which has a unique homotetramer structure, has been compared with the previously reported crystal structures of two orthologues from Escherichia coli and Aeropyrum pernix. In contrast to the similar alpha/beta-barrel fold of the monomers, substantial quaternary structural differences are observed between these three enzymes. Further comparison of the subunit-subunit interface areas of these aldolases showed a clear positive correlation between the interface area and the living temperature of the source organism. From these results, it is concluded that the oligomeric state of 2-deoxyribose-5-phosphate aldolase is important for the thermostability and not for the catalytic function.


Acta Crystallographica Section D-biological Crystallography | 2003

Crystallization and preliminary X-ray crystallographic studies of NADP-dependent 3-hydroxyisobutyrate dehydrogenase from Thermus thermophilus HB8

Neratur K. Lokanath; Ikuya Shiromizu; Yuichi Nodake; Mitsuaki Sugahara; Shigeyuki Yokoyama; Seiki Kuramitsu; Masashi Miyano; Naoki Kunishima

3-Hydroxyisobutyrate, a central metabolite in the valine catabolic pathway, is reversibly oxidized to methylmalonate semialdehyde by a specific NADP-dependent dehydrogenase (HIBADH). HIBADH from Thermus thermophilus HB8 has been overexpressed in Escherichia coli and crystallized by the microbatch method using lithium chloride as a precipitant at 296 K. X-ray diffraction data have been collected to 1.80 A resolution at 100 K using synchrotron radiation. The crystals belong to the orthorhombic space group P2(1)2(1)2(1), with unit-cell parameters a = 85.878, b = 106.367, c = 168.639 A. A homotetramer of HIBADH is likely to be present in the asymmetric unit, giving a V(M) of 3.0 A(3) Da(-1) and a solvent content of 59.3%.


Journal of Molecular Biology | 2005

Crystal Structure of Novel NADP-dependent 3-Hydroxyisobutyrate Dehydrogenase from Thermus thermophilus HB8

Neratur K. Lokanath; Noriyasu Ohshima; Koji Takio; Ikuya Shiromizu; Nobuo Okazaki; Seiki Kuramitsu; Shigeyuki Yokoyama; Masashi Miyano; Naoki Kunishima


Acta Crystallographica Section D-biological Crystallography | 2011

Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4.

Mutsuko Kukimoto-Niino; Alexander A. Tokmakov; Takaho Terada; Naomi Ohbayashi; Takako Fujimoto; Sumiko Gomi; Ikuya Shiromizu; Masaki Kawamoto; Tomokazu Matsusue; Mikako Shirouzu; Shigeyuki Yokoyama


Archive | 2003

Novel parp inhibitors

Ikuya Shiromizu; Kazuo Kato; Ichiro Yamamoto; Hajime Hamamoto


Chemical & Pharmaceutical Bulletin | 2004

Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors IV. A series of new derivatives containing a spiro[5H-oxazolo[3,2-a]pyrazine-2(3H),4'-piperidin]-5-one skeleton.

Fumihiko Saitoh; Takafumi Mukaihira; Hidemitsu Nishida; Tsutomu Satoh; Akihiro Okano; Yasunobu Yumiya; Munetaka Ohkouchi; Rumi Johka; Tomokazu Matsusue; Ikuya Shiromizu; Yoshitaka Hosaka; Miwa Matsumoto; Shuhei Ohnishi


Archive | 2002

Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same

Yutaka Kato; Yutaka Miyazaki; Hiroyasu Shimada; Tadashi Manabe; Ikuya Shiromizu; Atsushi Okamoto


Archive | 2000

Tricyclic compounds having spiro union

Hidemitsu Nishida; Fumihiko Saitoh; Kousuke Harada; Ikuya Shiromizu; Takafumi Mukaihira


Chemical & Pharmaceutical Bulletin | 2007

Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors(1-6) VI. A series of new derivatives containing N,S- and N,SO2-spiro acetal scaffolds.

Fumihiko Saitoh; Hidemitsu Nishida; Takafumi Mukaihira; Naoto Kosuga; Munetaka Ohkouchi; Tomokazu Matsusue; Ikuya Shiromizu; Yoshitaka Hosaka; Miwa Matsumoto; Ichiro Yamamoto


Bioorganic & Medicinal Chemistry Letters | 2006

Synthesis and evaluation of 4-substituted benzylamine derivatives as β-tryptase inhibitors

Yutaka Miyazaki; Yutaka Kato; Tadashi Manabe; Hiroyasu Shimada; Masashi Mizuno; Takayuki Egusa; Munetaka Ohkouchi; Ikuya Shiromizu; Tomokazu Matsusue; Ichiro Yamamoto

Collaboration


Dive into the Ikuya Shiromizu's collaboration.

Top Co-Authors

Avatar

Fumihiko Saitoh

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Hidemitsu Nishida

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Tomokazu Matsusue

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ichiro Yamamoto

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kousuke Harada

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Munetaka Ohkouchi

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge